Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$2.2 - $4.2 $132,000 - $252,000
-60,000 Reduced 54.55%
50,000 $119,000
Q1 2022

May 16, 2022

BUY
$2.83 - $8.69 $254,700 - $782,100
90,000 Added 450.0%
110,000 $443,000
Q4 2021

Feb 15, 2022

BUY
$8.31 - $14.92 $166,200 - $298,400
20,000 New
20,000 $166,000

Others Institutions Holding DNA

About Ginkgo Bioworks Holdings, Inc.


  • Ticker DNA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 1,287,779,968
  • Market Cap $13.2B
  • Description
  • Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...
More about DNA
Track This Portfolio

Track Sg3 Management, LLC Portfolio

Follow Sg3 Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg3 Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg3 Management, LLC with notifications on news.